Instalab
logoInstalab

Cortisol (PM)

The clearest signal of whether your stress hormone is following its normal daily rhythm or staying stuck in overdrive.

Should you take a Cortisol (PM) test?

This test is most useful if any of these apply to you.

Suspecting an Adrenal Issue
If you have unexplained fatigue, weight changes, or blood pressure that does not behave, this test helps reveal whether your adrenal rhythm is the cause.
Living With Chronic Stress
If high stress is your daily reality, this test shows whether your body has lost the ability to wind down its stress hormone in the afternoon.
Watching Your Heart Health
Flat afternoon cortisol patterns predict cardiovascular mortality in large cohorts, giving you a window into risk that standard lipid panels cannot see.
Optimizing Sleep and Recovery
If sleep is poor and you wake unrefreshed, an elevated afternoon cortisol can explain why your body cannot shift into recovery mode at night.

About Cortisol (PM)

In a healthy body, cortisol is high in the morning and falls through the day, hitting its low point in the evening. An afternoon cortisol that is still elevated when it should be coming down is one of the earliest signs that this rhythm has broken, a pattern linked to higher cardiovascular mortality, worse cancer survival, and disorders of the adrenal glands.

A single morning cortisol can look perfectly normal in someone with subtle hormone problems. The afternoon value is where the rhythm tends to fail first, which is why physicians use PM (afternoon) cortisol to investigate suspected Cushing syndrome, adrenal insufficiency, and the chronic stress patterns now linked to long-term health risk.

What Cortisol (PM) Actually Measures

Cortisol is the main glucocorticoid hormone, a chemical messenger your adrenal glands release in response to signals from your brain and pituitary. The full feedback loop is called the HPA axis (hypothalamic-pituitary-adrenal axis), the system that turns stress signals into hormone output. Cortisol mobilizes energy, modulates immunity, and helps regulate blood pressure.

Cortisol follows a daily rhythm. Levels peak shortly after waking and fall steadily through the day. The PM (afternoon) blood test, typically drawn around 4 PM, captures cortisol at a point where it should be well below morning values. When the afternoon number stays high, it suggests the daily rhythm is flat, and a flat rhythm is what the strongest outcome studies have linked to disease.

Cardiovascular Risk and Mortality

The most consistent finding across large cohorts is that a flatter cortisol rhythm, where afternoon and evening levels stay too high relative to morning, predicts cardiovascular death. In the Whitehall II study of 4,047 adults, a flatter daily slope of salivary cortisol was associated with higher all-cause mortality and especially cardiovascular mortality. The KORA-F3 study of 1,090 adults found the same pattern, with greater diurnal variation appearing protective.

In a cohort study of 2,305 hypertensive patients, steeper diurnal cortisol slopes were associated with reduced cardiovascular disease risk, while flatter slopes and higher midnight cortisol raised the risk. In 250 coronary artery bypass patients, a steeper presurgical diurnal slope predicted fewer adverse cardiac events and lower mortality. These studies measured cortisol at multiple times of day rather than PM alone, but they all converge on the same conclusion: when the afternoon and evening values fail to drop, the heart pays for it.

Cancer Survival

Higher evening cortisol has been linked to shorter survival in several cancer types. A pilot study in 40 head and neck cancer patients found that elevated evening cortisol predicted shorter progression-free survival. In 99 women with metastatic breast cancer, evening salivary cortisol was a sensitive marker of the flattened rhythm associated with poorer prognosis. Similar associations were reported in 62 lung cancer patients, 154 ovarian cancer patients, and an earlier landmark study of 104 metastatic breast cancer patients where abnormal diurnal cortisol predicted survival.

Most of these studies used salivary cortisol, which captures the unbound (free) fraction. Your PM blood test measures total cortisol, which behaves similarly across the day but uses different reference values. The directional signal, that afternoon and evening cortisol staying high carries prognostic weight, is consistent across both specimen types.

Cushing Syndrome and Hypercortisolism

Cushing syndrome is the disease of cortisol excess, caused by tumors of the pituitary, adrenal glands, or other tissues that drive chronic overproduction. It carries severe multisystem consequences and increased mortality. Because cortisol normally falls toward the end of the day, an inappropriately high afternoon or late-night value is one of the earliest signals.

In a meta-analysis of 139 studies including 14,140 participants, midnight serum cortisol had pooled sensitivity of 96.1% and specificity of 93.2% for detecting Cushing syndrome. Late-night salivary cortisol performed similarly. PM serum cortisol drawn earlier in the afternoon is less sensitive than midnight values but contributes to the diagnostic picture, especially when paired with morning cortisol to establish whether the daily rhythm is intact.

Adrenal Insufficiency

The opposite problem, an underactive adrenal gland, is also detected through cortisol testing. Morning cortisol is the primary screening test, but a low afternoon value alongside a low morning value strengthens the case. In a study of 416 outpatients, basal cortisol drawn between 9 AM and 1 PM had an area under the curve of 0.82 for diagnosing adrenal insufficiency, with values below 85 nmol/L showing 99.7% specificity. An ACTH stimulation test confirms the diagnosis.

Mental Health and Cognitive Risk

Elevated evening cortisol shows up repeatedly in research on depression, anxiety, and dementia risk. In a study of 90 full-time workers in Cartagena, Colombia, state anxiety was most strongly associated with elevated evening cortisol and triglycerides. A meta-analysis on adolescent cortisol and depression found that elevated nocturnal cortisol was a risk factor for major depressive disorder. A long-term cohort study using repeated 24-hour urinary cortisol found that higher within-person cortisol variability independently predicted increased Alzheimer's risk.

These studies used salivary, urinary, or nighttime serum cortisol rather than the standard PM blood draw. The biological signal of an afternoon cortisol that fails to drop is consistent with the broader pattern of HPA axis dysregulation that these studies describe.

Reference Ranges

These ranges come from a Swedish laboratory using radioimmunoassay in 197 healthy adults. They are illustrative orientation, not a target. Your lab will likely report different numbers and may use different units. Compare your results within the same lab over time for the most meaningful trend.

Time of DayReference Range (Serum)What It Suggests
8 AM (morning)200 to 800 nmol/L (about 7 to 29 µg/dL)Normal morning peak
4 PM (afternoon)Should be substantially lower than morning valueNormal daily decline beginning
10 PM (evening)Below 300 nmol/L (about 11 µg/dL)Normal nighttime trough

Many US labs report cortisol in µg/dL. To convert nmol/L to µg/dL, divide by approximately 27.6. The ratio between your morning and afternoon value matters more than the afternoon number alone. A healthy pattern shows the afternoon value at roughly half the morning value or lower.

Why a Single Reading Is Not Enough

Cortisol is one of the most variable hormones in the body. Within-person variation can account for roughly 50% to 73% of total variance in diurnal cortisol measures. A reliability analysis of diurnal salivary cortisol concluded that detecting between-person differences requires at least 3 days of sampling for the mean, 4 to 8 days for area-under-the-curve measures, and up to 10 days for slope. Detecting within-person change over time requires similar repetition.

Practically, this means a single PM cortisol can mislead in either direction. Get a baseline, retest in 3 to 6 months if you are working on sleep, stress, or any intervention that might affect the HPA axis, and then at least annually to track your trend. Always sample at the same time of day to make values comparable. If results are abnormal, the next step is rarely to act on one number; it is to repeat the measurement and pair it with a morning cortisol drawn the same day.

When Results Can Be Misleading

  • Acute stress before the draw: physical or emotional stress, including the venipuncture itself, can spike cortisol within minutes. Sit quietly for 10 to 15 minutes before the blood draw.
  • Recent intense exercise: moderate to vigorous exercise transiently raises cortisol. A study in 12 trained men showed cortisol rises with moderate to high intensity exercise and falls with very low intensity. Avoid hard workouts in the hours before the test.
  • Oral contraceptives: women on oral contraceptives showed roughly double the morning and evening cortisol of women not on them, because the pill raises cortisol-binding globulin. Total cortisol rises even though free, biologically active cortisol may be unchanged.
  • Pregnancy, kidney disease, or systemic illness: these conditions alter cortisol binding proteins and clearance. In chronic kidney disease, worsening kidney function is linked to altered cortisol dynamics that can mimic hypercortisolism.

What to Do With an Abnormal Result

An isolated abnormal PM cortisol is rarely diagnostic on its own. If your afternoon value is high relative to a morning draw, the standard next step is a 1 mg overnight dexamethasone suppression test, which checks whether your body can shut off cortisol production when given a synthetic steroid. A late-night salivary cortisol or 24-hour urinary free cortisol can confirm. If your afternoon value is low alongside a low morning cortisol, an ACTH stimulation test rules in or out adrenal insufficiency.

Repeated abnormal results, especially when paired with symptoms (weight gain, easy bruising, hypertension, mood changes, fatigue, or muscle weakness), warrant referral to an endocrinologist. If your numbers are borderline and you have no symptoms but a flat daily rhythm, the workup shifts toward the lifestyle factors driving chronic HPA activation: sleep, stress load, alcohol, and exercise patterns.

What Moves This Biomarker

Evidence-backed interventions that affect your Cortisol (PM) level

Decrease
Steroidogenesis inhibitors (osilodrostat, metyrapone, ketoconazole)
These drugs are the medical first-line therapy when surgery cannot fully control Cushing syndrome. Osilodrostat blocks 11-beta-hydroxylase, an enzyme needed to produce cortisol, and reliably lowers cortisol toward normal in adult Cushing syndrome patients, with improvements in body weight, blood pressure, glucose, lipids, and quality of life. In a real-world study of 30 patients with mild autonomous cortisol secretion, evening metyrapone significantly reduced systolic and diastolic blood pressure without causing adrenal insufficiency.
MedicationStrong Evidence
Increase
Glucocorticoid replacement therapy (hydrocortisone, prednisone)
If you have diagnosed adrenal insufficiency, replacement glucocorticoids are essential. They restore cortisol availability and prevent adrenal crisis. Standard regimens replace cortisol but do not perfectly mimic the natural daily rhythm, which is one reason patients on replacement therapy still face higher long-term morbidity than the general population.
MedicationStrong Evidence
Decrease
Vigorous aerobic exercise as a regular practice
In a randomized trial of 83 adults, a single vigorous exercise bout (70% of heart rate reserve) reduced cortisol responses to a subsequent psychosocial stressor and sped recovery. A meta-analysis of physical activity and cortisol regulation found that higher physical activity is associated with a steeper diurnal cortisol slope, meaning the afternoon and evening drop becomes more pronounced. Regular high-intensity interval training also tends to lower baseline cortisol.
ExerciseModerate Evidence
Decrease
Ashwagandha (Withania somnifera) extract
A meta-analysis of randomized trials found Ashwagandha supplementation significantly reduced anxiety and stress, with an associated morning cortisol-lowering effect. A separate systematic review of plant-based interventions on the HPA axis confirmed Ashwagandha as the most consistent botanical with cortisol-lowering effects. The trials measured morning cortisol rather than PM cortisol, so direct effects on afternoon values are not established.
SupplementModerate Evidence
Decrease
Mindfulness and meditation-based stress management
A meta-analysis of stress management interventions found that mindfulness and meditation produced the largest cortisol-lowering effects compared to talking therapies and mind-body therapies. A randomized trial of cognitive behavioral stress management in 235 breast cancer patients reduced cortisol and cancer-related distress. These trials largely used salivary cortisol or single-time-point serum cortisol; effects on a 4 PM blood cortisol have not been directly tested in most studies.
LifestyleModerate Evidence
Decrease
Combined exercise and hypocaloric Mediterranean diet
A randomized trial of 85 women recovering from early-stage breast cancer found that a 6-month combined exercise and hypocaloric healthy eating program reduced depressive symptoms and normalized HPA axis regulation, including cortisol patterns. The intervention shifted a flatter, dysregulated cortisol pattern toward a healthier diurnal rhythm.
LifestyleModerate Evidence
Decrease
Green-Mediterranean diet rich in polyphenols
In the DIRECT-PLUS randomized trial of 294 adults, long-term adherence to a green-Mediterranean diet (enriched with walnuts, green tea, and Mankai duckweed and lower in red meat) lowered fasting morning cortisol independent of weight loss. The trial measured morning cortisol rather than PM cortisol, so the direct effect on afternoon values has not been confirmed, but a lower overall cortisol load is consistent with broader cardiometabolic benefit.
DietModest Evidence

Frequently Asked Questions

References

33 studies
  1. Kumari M, Shipley M, Stafford M, Kivimaki MThe Journal of Clinical Endocrinology and Metabolism2011
  2. Gan L, Li N, Heizati M, Lin M, Zhu Q, Hong J, Wu T, Tong L, Xiamili Z, Lin YEuropean Journal of Endocrinology2022
  3. Ronaldson a, Kidd T, Poole L, Leigh E, Jahangiri M, Steptoe aThe Journal of Clinical Endocrinology and Metabolism2015